Overall Technical outlook

Price Summary

In today's trading session, VRTX's shares slumped by -2.58%, marking a poor day.
On 2026-03-13, Vertex Pharmaceuticals Incorporated's stock opened at 481.79, reached a high of 486.66, dropped to a low of 469.08, and closed down -2.58% at 469.34, with a trading volume of 1097500 shares.
Over the past 52 weeks, the stock reached a maximum price of 513.76 and a minimum price of 366.54.

Technicals

Support and Resistance: At 469.34, the price is supported at 463.13 and faces resistance at 484.15. This range suggests that the price for VRTX might stay between these levels, with 463.13 acting as a floor and 484.15 as a ceiling.
VRTX supportResistance ec0d6f
Support/Resistance for VRTX


Aroon: The AROON is in a neutral stance, with no clear signals for movement up or down. This neutral position indicates a potential period of consolidation or uncertainty in the market.
VRTX aroon ec0d6f
Aroon chart for Vertex Pharmaceuticals Incorporated


Bol. Bands: The BOLL BANDS is neutral, showing no definitive signals of a trend either upward or downward. This neutral stance indicates a period of market indecision, where the direction is unclear.
VRTX bbands ec0d6f
Bolinger Bands chart for Vertex Pharmaceuticals Incorporated


Parabolic SAR: The PSAR remains bullish in its outlook, establishing a key support level that could serve as a foundation for further upward movement. This persistent bullish stance suggests that the market may continue to trend higher, with the established support providing a potential safety net for investors.
VRTX psar ec0d6f
Parabolic Stop and Reverse chart for Vertex Pharmaceuticals Incorporated


Stochastic: The STOCHASTIC is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
VRTX stoch ec0d6f
Stochastic chart for Vertex Pharmaceuticals Incorporated


Tripple Moving Agerage: The 20, 50, and 100 moving averages are aligned bearishly, signaling a downtrend. However, the slopes of the 20 and 50 SMAs are starting to waver, indicating that this bearish momentum might be losing strength. This could suggest an upcoming shift towards bullish price action, as the market's current downward trend may be approaching a reversal, potentially leading to a new upward move.
VRTX trippleSMA ec0d6f
Tripple SMA chart for Vertex Pharmaceuticals Incorporated


A thorough analysis of a company involves looking beyond its stock price movements and trading patterns. You must also examine its fundamentals, which include profitability, growth prospects, and competitive advantages. Additionally, the industry in which the company operates provides important context, as factors like technological innovations, regulation, and market demand influence performance. By integrating this information with technical analysis, more accurate predictions about the company's future can be made.